Dr. Max Wolff | Science Division of the MIND Foundation https://insight-conference.eu/speaker/max-wolff/ In recent years, several early-phase clinical trials have provided preliminary evidence that psychedelic therapy – treating patients with psilocybin, LSD, or the DMT-containing plant
[More]